{"filter":{"phase":null,"status":null,"sponsor":null},"count":50,"items":[{"nct_id":"NCT06860607","brief_title":"Environment and Alcohol: A Pilot Study","phase":"PHASE1","study_type":"INTERVENTIONAL","overall_status":"RECRUITING","lead_sponsor_name":"National Institute on Drug Abuse (NIDA)","lead_sponsor_class":"NIH","start_date":"2026-05-21","primary_completion_date":"2027-03-01","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT06860607","external_url":"https://clinicaltrials.gov/study/NCT06860607"},{"nct_id":"NCT07591623","brief_title":"OCRA Distress & Unmet Needs","phase":"NA","study_type":"INTERVENTIONAL","overall_status":"NOT_YET_RECRUITING","lead_sponsor_name":"M.D. Anderson Cancer Center","lead_sponsor_class":"OTHER","start_date":"2026-10-01","primary_completion_date":"2027-03-31","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT07591623","external_url":"https://clinicaltrials.gov/study/NCT07591623"},{"nct_id":"NCT07540286","brief_title":"A Cohort Study on the Safety and Efficacy of XH-02 in Treating Hypoparathyroidism","phase":"PHASE2","study_type":"INTERVENTIONAL","overall_status":"RECRUITING","lead_sponsor_name":"Peking Union Medical College Hospital","lead_sponsor_class":"OTHER","start_date":"2026-04-13","primary_completion_date":"2030-04-30","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT07540286","external_url":"https://clinicaltrials.gov/study/NCT07540286"},{"nct_id":"NCT07593703","brief_title":"Evaluation of the Mental, Physical and Social Conditions of Prison Entrants in the Nord-Pas-de-Calais Region\" - Cross-sectional Survey Representative Sample, Prevalence Study","phase":null,"study_type":"OBSERVATIONAL","overall_status":"COMPLETED","lead_sponsor_name":"University Hospital, Lille","lead_sponsor_class":"OTHER","start_date":"2014-03-10","primary_completion_date":"2017-03-09","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT07593703","external_url":"https://clinicaltrials.gov/study/NCT07593703"},{"nct_id":"NCT07593781","brief_title":"rESWT vs LLLT for Cervical Myofascial Pain","phase":"NA","study_type":"INTERVENTIONAL","overall_status":"COMPLETED","lead_sponsor_name":"Indonesia University","lead_sponsor_class":"OTHER","start_date":"2024-10-01","primary_completion_date":"2025-08-30","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT07593781","external_url":"https://clinicaltrials.gov/study/NCT07593781"},{"nct_id":"NCT06854627","brief_title":"Effect of Continuous Prolonged Prone Position Versus Intermittent Daily Prone Position in ARDS","phase":"NA","study_type":"INTERVENTIONAL","overall_status":"RECRUITING","lead_sponsor_name":"Pontificia Universidad Catolica de Chile","lead_sponsor_class":"OTHER","start_date":"2025-04-07","primary_completion_date":"2027-10","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT06854627","external_url":"https://clinicaltrials.gov/study/NCT06854627"},{"nct_id":"NCT07592117","brief_title":"Assessing the Effects of Cool Roofs on Indoor Environments and Health in Tavua, Fiji","phase":"NA","study_type":"INTERVENTIONAL","overall_status":"NOT_YET_RECRUITING","lead_sponsor_name":"Aditi Bunker","lead_sponsor_class":"OTHER","start_date":"2026-05-18","primary_completion_date":"2027-09-01","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT07592117","external_url":"https://clinicaltrials.gov/study/NCT07592117"},{"nct_id":"NCT07592026","brief_title":"Evaluation of Slit-like Adjusted Mathieu Versus Onlay Island Flap for Hypospadias Repair in Pediatrics","phase":"NA","study_type":"INTERVENTIONAL","overall_status":"COMPLETED","lead_sponsor_name":"Al-Azhar University","lead_sponsor_class":"OTHER","start_date":"2020-05-01","primary_completion_date":"2025-10-31","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT07592026","external_url":"https://clinicaltrials.gov/study/NCT07592026"},{"nct_id":"NCT05666518","brief_title":"A Study to Learn More About the Safety of the Drug Vericiguat in Japanese People With Chronic Heart Failure Who Will be Receiving Vericiguat Under Real-world Conditions","phase":null,"study_type":"OBSERVATIONAL","overall_status":"RECRUITING","lead_sponsor_name":"Bayer","lead_sponsor_class":"INDUSTRY","start_date":"2022-08-31","primary_completion_date":"2027-12-31","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT05666518","external_url":"https://clinicaltrials.gov/study/NCT05666518"},{"nct_id":"NCT00911118","brief_title":"Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer","phase":"PHASE1","study_type":"INTERVENTIONAL","overall_status":"COMPLETED","lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","lead_sponsor_class":"OTHER","start_date":"2009-05-26","primary_completion_date":"2026-05-14","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT00911118","external_url":"https://clinicaltrials.gov/study/NCT00911118"},{"nct_id":"NCT06533644","brief_title":"A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer","phase":"PHASE2","study_type":"INTERVENTIONAL","overall_status":"RECRUITING","lead_sponsor_name":"Syncromune, Inc.","lead_sponsor_class":"INDUSTRY","start_date":"2025-05-29","primary_completion_date":"2028-04-14","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT06533644","external_url":"https://clinicaltrials.gov/study/NCT06533644"},{"nct_id":"NCT05158166","brief_title":"DaxibotulinumtoxinA Injection for Treatment of Adductor Spasmodic Dysphonia","phase":"PHASE1,PHASE2","study_type":"INTERVENTIONAL","overall_status":"COMPLETED","lead_sponsor_name":"University of California, San Francisco","lead_sponsor_class":"OTHER","start_date":"2023-10-13","primary_completion_date":"2025-03-01","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT05158166","external_url":"https://clinicaltrials.gov/study/NCT05158166"},{"nct_id":"NCT07593560","brief_title":"Deep Learning for Early Scoliosis Detection Using mmWave Radar Gait Data","phase":null,"study_type":"OBSERVATIONAL","overall_status":"NOT_YET_RECRUITING","lead_sponsor_name":"Gebze Technical University","lead_sponsor_class":"OTHER","start_date":"2026-06","primary_completion_date":"2027-12","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT07593560","external_url":"https://clinicaltrials.gov/study/NCT07593560"},{"nct_id":"NCT00597012","brief_title":"Comparing Surgery Versus Standard Physical Therapy in Treating People With a Meniscal Tear and Osteoarthritis","phase":"NA","study_type":"INTERVENTIONAL","overall_status":"COMPLETED","lead_sponsor_name":"Brigham and Women's Hospital","lead_sponsor_class":"OTHER","start_date":"2008-05","primary_completion_date":"2012-02","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT00597012","external_url":"https://clinicaltrials.gov/study/NCT00597012"},{"nct_id":"NCT07511049","brief_title":"Intravenous Brincidofovir as an Antiviral for Treatment of Progressive Multifocal Leukoencephalopathy: A Pilot Study","phase":"PHASE2","study_type":"INTERVENTIONAL","overall_status":"RECRUITING","lead_sponsor_name":"National Institute of Neurological Disorders and Stroke (NINDS)","lead_sponsor_class":"NIH","start_date":"2026-05-21","primary_completion_date":"2029-12-31","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT07511049","external_url":"https://clinicaltrials.gov/study/NCT07511049"},{"nct_id":"NCT07428993","brief_title":"Evaluating Efficacy of B7-H3-CAR T Cells Administered at the End of Upfront Map Chemotherapy in Patients With Newly Diagnosed High-Risk Osteosarcoma","phase":"PHASE2","study_type":"INTERVENTIONAL","overall_status":"RECRUITING","lead_sponsor_name":"St. Jude Children's Research Hospital","lead_sponsor_class":"OTHER","start_date":"2026-06","primary_completion_date":"2034-12","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT07428993","external_url":"https://clinicaltrials.gov/study/NCT07428993"},{"nct_id":"NCT06140615","brief_title":"Lung Ultrasound - Prospective Study","phase":"NA","study_type":"INTERVENTIONAL","overall_status":"COMPLETED","lead_sponsor_name":"University of Wisconsin, Madison","lead_sponsor_class":"OTHER","start_date":"2023-12-11","primary_completion_date":"2026-02-01","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT06140615","external_url":"https://clinicaltrials.gov/study/NCT06140615"},{"nct_id":"NCT07592832","brief_title":"EFFECTS OF TWO ANESTHESİA TECHNİQUES ON INFLAMMATORY RESPONSE AND AMİNO ACİD METABOLİSM İN THYROİD SURGERY","phase":"NA","study_type":"INTERVENTIONAL","overall_status":"NOT_YET_RECRUITING","lead_sponsor_name":"Harran University","lead_sponsor_class":"OTHER","start_date":"2026-07-30","primary_completion_date":"2027-02-20","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT07592832","external_url":"https://clinicaltrials.gov/study/NCT07592832"},{"nct_id":"NCT07585630","brief_title":"A1Cantus vs. Placebo","phase":"PHASE2","study_type":"INTERVENTIONAL","overall_status":"NOT_YET_RECRUITING","lead_sponsor_name":"University of California, Riverside","lead_sponsor_class":"OTHER","start_date":"2026-06-15","primary_completion_date":"2027-12-15","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT07585630","external_url":"https://clinicaltrials.gov/study/NCT07585630"},{"nct_id":"NCT07585773","brief_title":"Effect of Laparoscopic Splenectomy on Renal Function in Cirrhotic Patients With Hypersplenism (2-Year Follow-Up)","phase":null,"study_type":"OBSERVATIONAL","overall_status":"NOT_YET_RECRUITING","lead_sponsor_name":"Northern Jiangsu People's Hospital","lead_sponsor_class":"OTHER","start_date":"2026-05-01","primary_completion_date":"2029-02-28","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT07585773","external_url":"https://clinicaltrials.gov/study/NCT07585773"},{"nct_id":"NCT07555886","brief_title":"Intervention in Executive Functions and Emotional Self-Regulation in Adolescents With Primary Dysmenorrhea","phase":"NA","study_type":"INTERVENTIONAL","overall_status":"NOT_YET_RECRUITING","lead_sponsor_name":"Universidad Autonoma de Baja California","lead_sponsor_class":"OTHER","start_date":"2026-08-30","primary_completion_date":"2026-10-30","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT07555886","external_url":"https://clinicaltrials.gov/study/NCT07555886"},{"nct_id":"NCT07401927","brief_title":"Preemptive Analgesia in Laparoscopic Hysterectomy","phase":null,"study_type":"OBSERVATIONAL","overall_status":"COMPLETED","lead_sponsor_name":"Giresun University","lead_sponsor_class":"OTHER","start_date":"2026-02-02","primary_completion_date":"2026-04-01","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT07401927","external_url":"https://clinicaltrials.gov/study/NCT07401927"},{"nct_id":"NCT06803888","brief_title":"Bariatric Surgery vs. Semaglutide vs. Tirzepatide","phase":"PHASE4","study_type":"INTERVENTIONAL","overall_status":"ACTIVE_NOT_RECRUITING","lead_sponsor_name":"Ali Aminian","lead_sponsor_class":"OTHER","start_date":"2025-01-29","primary_completion_date":"2027-07-01","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT06803888","external_url":"https://clinicaltrials.gov/study/NCT06803888"},{"nct_id":"NCT07400653","brief_title":"A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)","phase":"PHASE3","study_type":"INTERVENTIONAL","overall_status":"RECRUITING","lead_sponsor_name":"Pfizer","lead_sponsor_class":"INDUSTRY","start_date":"2026-02-24","primary_completion_date":"2027-10-12","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT07400653","external_url":"https://clinicaltrials.gov/study/NCT07400653"},{"nct_id":"NCT05588856","brief_title":"Doctor-patient Partnerships: the Key to a Better Standard of Medical Advice?","phase":null,"study_type":"OBSERVATIONAL","overall_status":"RECRUITING","lead_sponsor_name":"Singapore General Hospital","lead_sponsor_class":"OTHER","start_date":"2021-06-17","primary_completion_date":"2027-05-01","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT05588856","external_url":"https://clinicaltrials.gov/study/NCT05588856"},{"nct_id":"NCT07377656","brief_title":"Strengthening HPV Immunization Through EPI Leveraged Delivery","phase":"PHASE2","study_type":"INTERVENTIONAL","overall_status":"RECRUITING","lead_sponsor_name":"International Vaccine Institute","lead_sponsor_class":"OTHER","start_date":"2026-04-30","primary_completion_date":"2028-02-29","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT07377656","external_url":"https://clinicaltrials.gov/study/NCT07377656"},{"nct_id":"NCT07594132","brief_title":"Randomized Trial of Next Generation Fluoroscopy System vs. Conventional Fluoroscopy System in Endoscopy","phase":"NA","study_type":"INTERVENTIONAL","overall_status":"RECRUITING","lead_sponsor_name":"Orlando Health, Inc.","lead_sponsor_class":"OTHER","start_date":"2026-05","primary_completion_date":"2027-12","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT07594132","external_url":"https://clinicaltrials.gov/study/NCT07594132"},{"nct_id":"NCT06924632","brief_title":"Efficacy & Safety of Minoxidil SL Tablets in Men With AGA","phase":"PHASE3","study_type":"INTERVENTIONAL","overall_status":"COMPLETED","lead_sponsor_name":"Samson Clinical Operations Pty Ltd","lead_sponsor_class":"INDUSTRY","start_date":"2025-07-14","primary_completion_date":"2026-05-15","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT06924632","external_url":"https://clinicaltrials.gov/study/NCT06924632"},{"nct_id":"NCT07588165","brief_title":"Pain Assessment During Rapid Sequence Induction","phase":null,"study_type":"OBSERVATIONAL","overall_status":"NOT_YET_RECRUITING","lead_sponsor_name":"Centre Hospitalier Princesse Grace","lead_sponsor_class":"OTHER","start_date":"2026-05","primary_completion_date":"2028-05","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT07588165","external_url":"https://clinicaltrials.gov/study/NCT07588165"},{"nct_id":"NCT07214012","brief_title":"Planning Together: A Couple-based, Multi-level Prenatal Contraceptive Education Program for Economically Marginalized Families","phase":"NA","study_type":"INTERVENTIONAL","overall_status":"RECRUITING","lead_sponsor_name":"University of Tennessee Graduate School of Medicine","lead_sponsor_class":"OTHER","start_date":"2025-11-25","primary_completion_date":"2026-10-14","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT07214012","external_url":"https://clinicaltrials.gov/study/NCT07214012"},{"nct_id":"NCT07592572","brief_title":"A Study of the Effects of Itraconazole on LY4395089 in Healthy Participants","phase":"PHASE1","study_type":"INTERVENTIONAL","overall_status":"NOT_YET_RECRUITING","lead_sponsor_name":"Eli Lilly and Company","lead_sponsor_class":"INDUSTRY","start_date":"2026-05","primary_completion_date":"2026-07","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT07592572","external_url":"https://clinicaltrials.gov/study/NCT07592572"},{"nct_id":"NCT07593482","brief_title":"Bendamustine Versus Fludarabine/Cyclophosphamide for Lymphodepletion in Chimeric Antigen Receptor T-cell Immunotherapy (CAR-T): a Randomized Trial.","phase":"PHASE2","study_type":"INTERVENTIONAL","overall_status":"NOT_YET_RECRUITING","lead_sponsor_name":"Swiss Cancer Institute","lead_sponsor_class":"OTHER","start_date":"2026-09","primary_completion_date":"2029-03","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT07593482","external_url":"https://clinicaltrials.gov/study/NCT07593482"},{"nct_id":"NCT06041217","brief_title":"A Research Study to See How Well Semaglutide Helps People Who Have a Body Weight Above the Healthy Weight Range","phase":"PHASE3","study_type":"INTERVENTIONAL","overall_status":"COMPLETED","lead_sponsor_name":"Novo Nordisk A/S","lead_sponsor_class":"INDUSTRY","start_date":"2023-09-15","primary_completion_date":"2025-04-02","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT06041217","external_url":"https://clinicaltrials.gov/study/NCT06041217"},{"nct_id":"NCT05169515","brief_title":"A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma","phase":"PHASE1","study_type":"INTERVENTIONAL","overall_status":"RECRUITING","lead_sponsor_name":"Hoffmann-La Roche","lead_sponsor_class":"INDUSTRY","start_date":"2022-10-26","primary_completion_date":"2029-09-15","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT05169515","external_url":"https://clinicaltrials.gov/study/NCT05169515"},{"nct_id":"NCT07594080","brief_title":"Biomarkers of Environment Sensitivity","phase":"NA","study_type":"INTERVENTIONAL","overall_status":"ACTIVE_NOT_RECRUITING","lead_sponsor_name":"Semmelweis University","lead_sponsor_class":"OTHER","start_date":"2022-11-01","primary_completion_date":"2026-03-31","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT07594080","external_url":"https://clinicaltrials.gov/study/NCT07594080"},{"nct_id":"NCT07592780","brief_title":"Pathway to Peanut Tolerance","phase":"NA","study_type":"INTERVENTIONAL","overall_status":"RECRUITING","lead_sponsor_name":"Chinese University of Hong Kong","lead_sponsor_class":"OTHER","start_date":"2025-11-15","primary_completion_date":"2028-12-30","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT07592780","external_url":"https://clinicaltrials.gov/study/NCT07592780"},{"nct_id":"NCT07594431","brief_title":"Trial Comparing LATTICE Radiotherapy vs Moderately Dose-escalated Palliative Radiation for Patients With Metastases.","phase":"PHASE2","study_type":"INTERVENTIONAL","overall_status":"NOT_YET_RECRUITING","lead_sponsor_name":"Stanford University","lead_sponsor_class":"OTHER","start_date":"2026-08","primary_completion_date":"2028-08","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT07594431","external_url":"https://clinicaltrials.gov/study/NCT07594431"},{"nct_id":"NCT06960213","brief_title":"STOP-HAE: A Phase 3 Study of ADX-324 in HAE","phase":"PHASE3","study_type":"INTERVENTIONAL","overall_status":"RECRUITING","lead_sponsor_name":"ADARx Pharmaceuticals, Inc.","lead_sponsor_class":"INDUSTRY","start_date":"2025-08-28","primary_completion_date":"2027-06-30","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT06960213","external_url":"https://clinicaltrials.gov/study/NCT06960213"},{"nct_id":"NCT07592585","brief_title":"Phase III Clinical Study to Evaluate the Efficacy and Safety of VC005 in Adult and Adolescents With Mild to Moderate Atopic Dermatitis","phase":"PHASE3","study_type":"INTERVENTIONAL","overall_status":"NOT_YET_RECRUITING","lead_sponsor_name":"Jiangsu vcare pharmaceutical technology co., LTD","lead_sponsor_class":"INDUSTRY","start_date":"2026-05-30","primary_completion_date":"2028-05-30","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT07592585","external_url":"https://clinicaltrials.gov/study/NCT07592585"},{"nct_id":"NCT07355179","brief_title":"PLAY UP: An Intervention Program Through Active Play and Environmental Affordances","phase":"NA","study_type":"INTERVENTIONAL","overall_status":"ENROLLING_BY_INVITATION","lead_sponsor_name":"University of Évora","lead_sponsor_class":"OTHER","start_date":"2026-02-23","primary_completion_date":"2026-06-30","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT07355179","external_url":"https://clinicaltrials.gov/study/NCT07355179"},{"nct_id":"NCT07591844","brief_title":"Effect of Periodontal Therapy on Asprosin in Stable Angina","phase":"NA","study_type":"INTERVENTIONAL","overall_status":"NOT_YET_RECRUITING","lead_sponsor_name":"Ondokuz Mayıs University","lead_sponsor_class":"OTHER","start_date":"2026-05-20","primary_completion_date":"2026-08-20","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT07591844","external_url":"https://clinicaltrials.gov/study/NCT07591844"},{"nct_id":"NCT07589036","brief_title":"Effects of Dioscorea Yam Gruel on Blood Lipid Profiles in PCI Patients With Coronary Heart Disease","phase":"NA","study_type":"INTERVENTIONAL","overall_status":"COMPLETED","lead_sponsor_name":"900th Hospital of PLA Joint Logistic Support Force","lead_sponsor_class":"OTHER","start_date":"2024-01-10","primary_completion_date":"2025-03-15","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT07589036","external_url":"https://clinicaltrials.gov/study/NCT07589036"},{"nct_id":"NCT04661007","brief_title":"To Assess the Safety and Tolerability of Tafasitamab Alone or in Combination With Other Drugs in Japanese Participants With Non-Hodgkins Lymphoma (NHL)","phase":"PHASE1,PHASE2","study_type":"INTERVENTIONAL","overall_status":"ACTIVE_NOT_RECRUITING","lead_sponsor_name":"Incyte Biosciences Japan GK","lead_sponsor_class":"INDUSTRY","start_date":"2020-12-15","primary_completion_date":"2025-07-01","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT04661007","external_url":"https://clinicaltrials.gov/study/NCT04661007"},{"nct_id":"NCT05941273","brief_title":"A Study of the SING IMT in an Israeli Cohort","phase":"NA","study_type":"INTERVENTIONAL","overall_status":"WITHDRAWN","lead_sponsor_name":"VisionCare, Inc.","lead_sponsor_class":"INDUSTRY","start_date":"2023-07-30","primary_completion_date":"2024-01-30","why_stopped":"This decision is driven by the sponsor's strategic considerations.","last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT05941273","external_url":"https://clinicaltrials.gov/study/NCT05941273"},{"nct_id":"NCT07590154","brief_title":"Cross-sectional Functional Stratification Based on Psychometric Profiling and Machine Learning in Patients With Substance Use Disorders (SUD)","phase":null,"study_type":"OBSERVATIONAL","overall_status":"COMPLETED","lead_sponsor_name":"Lauro Gutiérrez Castro","lead_sponsor_class":"OTHER","start_date":"2024-03-25","primary_completion_date":"2026-02-18","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT07590154","external_url":"https://clinicaltrials.gov/study/NCT07590154"},{"nct_id":"NCT07328503","brief_title":"CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia","phase":"PHASE2","study_type":"INTERVENTIONAL","overall_status":"RECRUITING","lead_sponsor_name":"National Cancer Institute (NCI)","lead_sponsor_class":"NIH","start_date":"2026-05-21","primary_completion_date":"2030-01-31","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT07328503","external_url":"https://clinicaltrials.gov/study/NCT07328503"},{"nct_id":"NCT07499128","brief_title":"Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event","phase":"NA","study_type":"INTERVENTIONAL","overall_status":"NOT_YET_RECRUITING","lead_sponsor_name":"National Cancer Institute (NCI)","lead_sponsor_class":"NIH","start_date":"2026-05-21","primary_completion_date":"2029-06-30","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT07499128","external_url":"https://clinicaltrials.gov/study/NCT07499128"},{"nct_id":"NCT07093541","brief_title":"Expanded Access Program for Treatment With Ecopipam for Tourette's Disorder","phase":null,"study_type":"EXPANDED_ACCESS","overall_status":"AVAILABLE","lead_sponsor_name":"Emalex Biosciences Inc.","lead_sponsor_class":"INDUSTRY","start_date":null,"primary_completion_date":null,"why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT07093541","external_url":"https://clinicaltrials.gov/study/NCT07093541"},{"nct_id":"NCT07594288","brief_title":"Baveno Classification Versus Polysomnography in Obstructive Sleep Apnea","phase":null,"study_type":"OBSERVATIONAL","overall_status":"COMPLETED","lead_sponsor_name":"Hisar Intercontinental Hospital","lead_sponsor_class":"OTHER","start_date":"2016-01-01","primary_completion_date":"2024-06-30","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT07594288","external_url":"https://clinicaltrials.gov/study/NCT07594288"},{"nct_id":"NCT06247124","brief_title":"OPERATION WIPE OUT: Multi-Channel Communication Campaign to Promote HPV Vaccination in Chambers County, Alabama","phase":"NA","study_type":"INTERVENTIONAL","overall_status":"ACTIVE_NOT_RECRUITING","lead_sponsor_name":"University of Alabama at Birmingham","lead_sponsor_class":"OTHER","start_date":"2023-11-01","primary_completion_date":"2026-06-30","why_stopped":null,"last_update_date":"2026-05-18","url":"/api/v1/clinical/NCT06247124","external_url":"https://clinicaltrials.gov/study/NCT06247124"}]}